Note: Ingredients listed on restricted chemical lists
EC/CAS
205-592-6/143-22-6
Name of the chemical
2-(2-(2-butoxyethoxy)ethoxy)ethanol
Concentration
1≤X≤9,9
EC/CAS
203-906-6/111-77-3
Name of the chemical
2-(2-methoxyethoxy)-ethanol
Concentration
0<X<3
General Information
Revision date
2024-05-03
Product name
LCF 600 PLUS
1.2.1 Relevant identified uses
Low compressibility brake fluid for racing vehicles
1.2.2. Uses advised against
Uses other than those identified as relevant
Emergency telephone
+39 035 605 1111
Icons in SDS
Company Information
company name
Brembo N.V
e-mail address of the competent person responsible for the Safety Data Sheet
SDS@brembo.it
GHS Information
Signal word
WARNING
Hazard Codes
Hazard statements (CLP)
H361fd
Hazard statements
Code
Statements
H361fd
Suspected of damaging fertility; Suspected of damaging the unborn child
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
The mixture meets the criteria for classification in accordance with
Hazard pictograms
Hazard class(es) and category(ies)
Hazard statements
H361fd - Suspected of damaging fertility. Suspected of Repr. 2 damaging the unborn child. GHS 08 H361fd Suspected of damaging fertility. Suspected of damaging the unborn child.
2.2 Label elements
Label in accordance with
Signal word
WARNING
Precautionary statements
P202 Do not handle until all safety precautions have been read and understood. P280 Wear protective gloves / protective clothing / eye protection / face protection. P308 + P313 IF exposed or concerned: Get medical advice / attention. P405 Store locked up. P501 Dispose of contents/container in accordance with local / regional / national / international regulation.
Contains
Tris[2-[2-(2-methoxyethoxy)ethoxy]ethyl]orthoborate, 2-(2-methoxyethoxy)ethanol
2.3 Other hazards
The mixture does not contain substances at a concentration equal to or greater than 0,1% by weight, known to be: ▪ PBT and/or vPvB according to Annex XIII of REACH ; ▪ included in the Candidate list for having endocrine disrupting properties (art. 59(1)); ▪ identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation EU 2100/2017 or Commission Regulation EU 605/2018.
